Metlife (MET) Stock Forecast & Price Target

Compare

2,947 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MET Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Metlife

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$92.67

▲(33.99% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $92.67 with a high forecast of $100.00 and a low forecast of $84.00. The average price target represents a 33.99% change from the last price of $69.16.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","86":"$86","101":"$101","78.5":"$78.5","93.5":"$93.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$92.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$84.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,78.5,86,93.5,101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,75.29846153846154,77.35692307692307,79.41538461538461,81.47384615384615,83.53230769230768,85.59076923076923,87.64923076923077,89.7076923076923,91.76615384615384,93.82461538461538,95.88307692307691,97.94153846153846,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,74.73461538461538,76.22923076923077,77.72384615384615,79.21846153846154,80.71307692307693,82.2076923076923,83.7023076923077,85.19692307692307,86.69153846153846,88.18615384615384,89.68076923076923,91.17538461538462,{"y":92.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.24,74.0676923076923,74.89538461538461,75.72307692307692,76.55076923076923,77.37846153846154,78.20615384615384,79.03384615384616,79.86153846153846,80.68923076923076,81.51692307692308,82.34461538461538,83.1723076923077,{"y":84,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":83.691,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.816,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.582,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.972,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.33,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.404,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.202,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.764,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.684,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.767,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.378,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.262,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.24,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$100.00

Average Price Target$92.67

Lowest Price Target$84.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Kligerman

TD Cowen

$91→$88

Buy

27.24%

Upside

Assigned

03/11/26

TD Cowen Reaffirms Their Buy Rating on Metlife (MET)

Jimmy Bhullar

J.P. Morgan

$91

Buy

31.58%

Upside

Reiterated

03/05/26

J.P. Morgan Sticks to Their Buy Rating for Metlife (MET)

Bob Huang

Morgan Stanley

$101→$93

Buy

34.47%

Upside

Reiterated

03/03/26

Morgan Stanley Sticks to Its Buy Rating for Metlife (MET)

Elyse Greenspan

Wells Fargo

$97→$93

Buy

34.47%

Upside

Reiterated

02/25/26

MetLife price target lowered to $93 from $97 at Wells FargoMetLife price target lowered to $93 from $97 at Wells Fargo

Yaron Kinar

Mizuho Securities

$102→$100

Buy

44.59%

Upside

Reiterated

02/12/26

Metlife (MET) Gets a Buy from Mizuho Securities

Thomas Gallagher

Evercore ISI

$97→$95

Hold

37.36%

Upside

Reiterated

02/11/26

MetLife price target lowered to $95 from $97 at Evercore ISIMetLife price target lowered to $95 from $97 at Evercore ISI

Joshua Shanker

Bank of America Securities

―

Buy

―

Reiterated

02/05/26

Analysts Have Conflicting Sentiments on These Financial Companies: T Rowe Price (NASDAQ: TROW) and Metlife (NYSE: MET)

John Barnidge

Piper Sandler

$84

Hold

21.46%

Upside

Reiterated

02/05/26

Piper Sandler Sticks to Its Hold Rating for Metlife (MET)

Michael Ward CFA

UBS

$94→$98

Buy

41.70%

Upside

Reiterated

02/05/26

MetLife price target raised to $98 from $94 at UBSMetLife price target raised to $98 from $94 at UBS

Alex Scott

Barclays

$90→$92

Buy

33.02%

Upside

Reiterated

02/05/26

Metlife (MET) Gets a Buy from Barclays

Kevin Heal

Argus Research

$90

Buy

30.13%

Upside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Ryan Krueger

KBW

$92→$90

Buy

30.13%

Upside

Reiterated

11/11/25

MetLife price target lowered to $90 from $92 at Keefe BruyetteMetLife price target lowered to $90 from $92 at Keefe Bruyette

Jack Matten

BMO Capital

$82→$84

Hold

21.46%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Tracy Benguigui

Wolfe Research

$95

Buy

37.36%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Suneet Kamath

Jefferies

$100→$103

Buy

48.93%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Kligerman

TD Cowen

$91→$88

Buy

27.24%

Upside

Assigned

03/11/26

TD Cowen Reaffirms Their Buy Rating on Metlife (MET)

Jimmy Bhullar

J.P. Morgan

$91

Buy

31.58%

Upside

Reiterated

03/05/26

J.P. Morgan Sticks to Their Buy Rating for Metlife (MET)

Bob Huang

Morgan Stanley

$101→$93

Buy

34.47%

Upside

Reiterated

03/03/26

Morgan Stanley Sticks to Its Buy Rating for Metlife (MET)

Elyse Greenspan

Wells Fargo

$97→$93

Buy

34.47%

Upside

Reiterated

02/25/26

MetLife price target lowered to $93 from $97 at Wells FargoMetLife price target lowered to $93 from $97 at Wells Fargo

Yaron Kinar

Mizuho Securities

$102→$100

Buy

44.59%

Upside

Reiterated

02/12/26

Metlife (MET) Gets a Buy from Mizuho Securities

Thomas Gallagher

Evercore ISI

$97→$95

Hold

37.36%

Upside

Reiterated

02/11/26

MetLife price target lowered to $95 from $97 at Evercore ISIMetLife price target lowered to $95 from $97 at Evercore ISI

Joshua Shanker

Bank of America Securities

―

Buy

―

Reiterated

02/05/26

Analysts Have Conflicting Sentiments on These Financial Companies: T Rowe Price (NASDAQ: TROW) and Metlife (NYSE: MET)

John Barnidge

Piper Sandler

$84

Hold

21.46%

Upside

Reiterated

02/05/26

Piper Sandler Sticks to Its Hold Rating for Metlife (MET)

Michael Ward CFA

UBS

$94→$98

Buy

41.70%

Upside

Reiterated

02/05/26

MetLife price target raised to $98 from $94 at UBSMetLife price target raised to $98 from $94 at UBS

Alex Scott

Barclays

$90→$92

Buy

33.02%

Upside

Reiterated

02/05/26

Metlife (MET) Gets a Buy from Barclays

Kevin Heal

Argus Research

$90

Buy

30.13%

Upside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Ryan Krueger

KBW

$92→$90

Buy

30.13%

Upside

Reiterated

11/11/25

MetLife price target lowered to $90 from $92 at Keefe BruyetteMetLife price target lowered to $90 from $92 at Keefe Bruyette

Jack Matten

BMO Capital

$82→$84

Hold

21.46%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Tracy Benguigui

Wolfe Research

$95

Buy

37.36%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Suneet Kamath

Jefferies

$100→$103

Buy

48.93%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Stocks with the Highest Top Analyst Consensus in the Financial Sector

xxx

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

3 Months

xxx

Success Rate

23/35 ratings generated profit

Average Return

+4.16%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.71% of your transactions generating a profit, with an average return of +4.16% per trade.

1 Year

Suneet KamathJefferies

Success Rate

27/35 ratings generated profit

Average Return

+10.47%

reiterated a buy rating 7 months ago

Copying Suneet Kamath's trades and holding each position for 1 Year would result in 77.14% of your transactions generating a profit, with an average return of +10.47% per trade.

2 Years

xxx

Success Rate

24/35 ratings generated profit

Average Return

+10.11%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 68.57% of your transactions generating a profit, with an average return of +10.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MET has received 26 Buy Ratings, 29 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 92.67.

Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $2.19 with a range of $2.11 to $2.32. The previous quarter’s EPS was $2.49. MET beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $19.29B with a range of $18.57B to $19.86B. The previous quarter’s sales results were $23.81B. MET beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Stock Forecast FAQ

What is MET’s average 12-month price target, according to analysts?

Based on analyst ratings, Metlife’s 12-month average price target is 92.67.

What is MET’s upside potential, based on the analysts’ average price target?

Metlife has 33.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MET a Buy, Sell or Hold?

Metlife has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Metlife’s price target?

The average price target for Metlife is 92.67. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $100.00 ,the lowest forecast is $84.00. The average price target represents 33.99% Increase from the current price of $69.16.

What do analysts say about Metlife?

Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of MET?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Metlife (MET) Stock Forecast & Price Target

MET Analyst Ratings

MET Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Metlife

MET Analyst Recommendation Trends

MET Financial Forecast

MET Earnings Forecast

MET Sales Forecast

MET Stock Forecast FAQ

Detailed List of Analyst Forecasts